Fabrazyme anvendes som ensymerstatningsbehandling ved Fabry sygdom, hvor α- galaktosidase enzymaktiviteten enten helt mangler eller er lavere end normalt.
Fabrazyme is used as enzyme replacement therapy in Fabry disease, where the level of α- galactosidase enzyme activity is absent or lower than normal.